Retatrutide | China | Manufacturer
US$ 28.24
tirzepatide and osteoarthritis More Cost-Effective Than Semaglutide in Knee Impact of Tirzepatide on Musculoskeletal
Description
Yabe D, Kawamori D, Seino Y, Oura T, Takeuchi M
Diabetes 41 , 467473 (2023)
It works
Do the math on a real scenario
The average rate of decline in eGFR was markedly lower in the tirzepatide groups when compared to the insulin glargine group (-1.4 mL/min/1.73 m 2 /year vs
Our comparison of semaglutide versus tirzepatide versus retatrutide provides the most current analysis of how these medications stack up against each other
